Back to Semaglutide research
semaglutide glp 1 agonist other 2026-04-10 PubMed

Advanced Oral Semaglutide 'Rybelsus R2' Rebranded as Ozempic Oral

In brief: Rybelsus R2 rebranded as Ozempic.

Abstract

In brief: Rybelsus R2 rebranded as Ozempic. Journal: The Medical letter on drugs and therapeutics (2026) DOI: 10.58347/tml.2026.1752f

semaglutide glp 1 agonist glp-1r
Source: pubmed:41961538 · Ingested 2026-04-10 · Digest: gemini-2.5-flash